FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

5 results

avsola
(infliximab-axxq)
Amgen Inc
Usage: AVSOLA is indicated for reducing signs and symptoms, inducing and maintaining remission in moderately to severely active Crohn's disease (adult and pediatric), ulcerative colitis (adult and pediatric), and other conditions like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis.
inflectra
(infliximab-dyyb)
Pfizer Laboratories Div Pfizer Inc
Usage: INFLECTRA is indicated for treating moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults and pediatric patients aged 6 and older, particularly in cases unresponsive to conventional therapies.
lialda
(mesalamine)
Takeda Pharmaceuticals America, Inc.
Usage: LIALDA is indicated for the induction and maintenance of remission in adults with mildly to moderately active ulcerative colitis and for treating mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
remicade
(INFLIXIMAB)
Janssen Biotech, Inc.
Usage: REMICADE is indicated for treating moderate to severe Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults. It is also approved for pediatric Crohn's and ulcerative colitis. The drug helps induce and maintain remission and reduce symptoms.
renflexis
(infliximab)
Organon LLC
Usage: RENFLEXIS is indicated for reducing symptoms and maintaining remission in adults and pediatric patients with moderately to severely active Crohn's disease and ulcerative colitis. It is also used for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis, often in combination with other therapies.

Medications for Pediatric Ulcerative Colitis

avsola

inflectra

lialda

remicade

renflexis